Human NCF2 ELISA Kit (V2LY-0626-LY3998)

Huang, N., Zhang, J., Kuang, S., Li, Z., Zhao, H., Wu, J., ... & Wang, L. (2023). Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma. Cancer Medicine, 12(7), 8991-9004.

Bakutenko, I. Y., Haurylchyk, I. D., Nikitchenko, N. V., Sechko, E. V., Kozyro, I. A., Tchitchko, A. M., ... & Ryabokon, N. I. (2022). Neutrophil cytosolic factor 2 (NCF2) gene polymorphism is associated with juvenile‐onset systemic lupus erythematosus, but probably not with other autoimmune rheumatic diseases in children. Molecular Genetics & Genomic Medicine, 10(1), e1859.

Azarova, I. E., Klyosova, E. Y., Kolomoets, I. I., & Polonikov, A. V. (2022). Polymorphic Variants of the Neutrophil Cytosolic Factor 2 Gene: Associations with Susceptibility to Type 2 Diabetes Mellitus and Cardiovascular Autonomic Neuropathy. Russian Journal of Genetics, 58(5), 593-602.

Roth, I. L., Salamon, P., Freund, T., Gadot, Y. B. D., Baron, S., Hershkovitz, T., ... & Hagin, D. (2020). Novel NCF2 mutation causing chronic granulomatous disease. Journal of Clinical Immunology, 40, 977-986.

Qin, K., Zheng, Z., He, Y., Gao, Y., Shi, H., Mo, S., ... & Rong, J. (2020). High expression of neutrophil cytosolic factor 2 (NCF2) is associated with aggressive features and poor prognosis of esophageal squamous cell carcinoma. International journal of clinical and experimental pathology, 13(12), 3033.

AlKhater, S. A., Deswarte, C., Casanova, J. L., & Bustamante, J. (2020). A novel variant in the neutrophil cytosolic factor 2 (NCF2) gene results in severe disseminated BCG infectious disease: A clinical report and literature review. Molecular genetics & genomic medicine, 8(6), e1237.

Wang, D., Liu, J., Chen, Q., Yang, R., & Jiang, Q. (2020). Upregulation of glutaminase 2 and neutrophil cytosolic factor 2 is associated with the poor prognosis of glioblastoma. Biomarkers in Medicine, 14(16), 1585-1597.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols